Your browser doesn't support javascript.
loading
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia.
Page, Michael M; Ellis, Katrina L; Chan, Dick C; Pang, Jing; Hooper, Amanda J; Bell, Damon A; Burnett, John R; Moses, Eric K; Watts, Gerald F.
Afiliação
  • Page MM; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts); Department of Clinical Biochemistry, Western Diagnostic Pathology, Perth, Australia (Dr Page).
  • Ellis KL; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts); School of Population and Global Health, The University of Western Australia, Perth, Australia (Dr Ellis).
  • Chan DC; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts).
  • Pang J; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts).
  • Hooper AJ; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts); Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital and Fiona Stanley Hospital, P
  • Bell DA; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts); Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia (Drs Bell, Burnett, and Watts);
  • Burnett JR; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts); Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia (Drs Bell, Burnett, and Watts);
  • Moses EK; Menzies Institute for Medical Research, The University of Tasmania, Hobart, Australia (Dr Moses).
  • Watts GF; School of Medicine, Faculty of Medicine and Health Sciences, The University of Western Australia, Perth, Australia (Drs Page, Ellis, Chan, Pang, Hooper, Bell, Burnett, and Watts); Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia (Drs Bell, Burnett, and Watts).
J Clin Lipidol ; 16(4): 525-529, 2022.
Article em En | MEDLINE | ID: mdl-35739058
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fibronectinas / Hiperlipoproteinemia Tipo II Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Lipidol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Fibronectinas / Hiperlipoproteinemia Tipo II Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Lipidol Ano de publicação: 2022 Tipo de documento: Article